Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

The global burden of hepatitis C.

Lavanchy D.

Liver Int. 2009 Jan;29 Suppl 1:74-81. doi: 10.1111/j.1478-3231.2008.01934.x. Review.

PMID:
19207969
2.

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.

Monforte Ad, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

AIDS. 2008 Oct 18;22(16):2143-53. doi: 10.1097/QAD.0b013e3283112b77.

3.

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.

Antiretroviral Therapy Cohort Collaboration.

Lancet. 2008 Jul 26;372(9635):293-9. doi: 10.1016/S0140-6736(08)61113-7.

4.

Changes in the risk of death after HIV seroconversion compared with mortality in the general population.

Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K; CASCADE Collaboration.

JAMA. 2008 Jul 2;300(1):51-9. doi: 10.1001/jama.300.1.51.

PMID:
18594040
5.

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

Strategies for Management of Antiretroviral Therapy (SMART) Study Group, Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, Girard PM, Grund B, Law M, Losso MH, Palfreeman A, Wood R.

J Infect Dis. 2008 Apr 15;197(8):1133-44. doi: 10.1086/586713.

PMID:
18476292
6.

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.

Baker JV, Peng G, Rapkin J, Abrams DI, Silverberg MJ, MacArthur RD, Cavert WP, Henry WK, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

AIDS. 2008 Apr 23;22(7):841-8. doi: 10.1097/QAD.0b013e3282f7cb76.

7.

Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil.

Pacheco AG, Tuboi SH, Faulhaber JC, Harrison LH, Schechter M.

PLoS One. 2008 Jan 30;3(1):e1531. doi: 10.1371/journal.pone.0001531.

8.

Survival following HIV infection of a cohort followed up from seroconversion in the UK.

Ewings FM, Bhaskaran K, McLean K, Hawkins D, Fisher M, Fidler S, Gilson R, Nock D, Brettle R, Johnson M, Phillips A, Porter K; UK Register of HIV Seroconverters.

AIDS. 2008 Jan 2;22(1):89-95.

PMID:
18090396
9.

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM.

Lancet. 2007 Jul 7;370(9581):59-67. Review.

PMID:
17617273
10.

Class of antiretroviral drugs and the risk of myocardial infarction.

DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte Ad, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD.

N Engl J Med. 2007 Apr 26;356(17):1723-35.

12.

Survival of persons with and without HIV infection in Denmark, 1995-2005.

Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sørensen HT, Vaeth M, Obel N.

Ann Intern Med. 2007 Jan 16;146(2):87-95.

PMID:
17227932
13.
14.

Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.

Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV.

Ann Intern Med. 2006 Sep 19;145(6):397-406.

PMID:
16983127
15.

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte Ad, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD.

Arch Intern Med. 2006 Aug 14-28;166(15):1632-41.

PMID:
16908797
16.

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD; HIV Outpatient Study Investigators.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34.

PMID:
16878047
17.

Risk factors and causes of death in the Australian HIV Observational Database.

Petoumenos K, Law MG; Australian HIV Observational Database.

Sex Health. 2006 May;3(2):103-12.

PMID:
16800396
18.

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, Wood R, Laurent C, Sprinz E, Seyler C, Bangsberg DR, Balestre E, Sterne JA, May M, Egger M; Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration; ART Cohort Collaboration (ART-CC) groups.

Lancet. 2006 Mar 11;367(9513):817-24. Erratum in: Lancet. 2006 Jun 10;367(9526):1902.

PMID:
16530575
19.

Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.

Smit C, Geskus R, Walker S, Sabin C, Coutinho R, Porter K, Prins M; CASCADE Collaboration.

AIDS. 2006 Mar 21;20(5):741-9.

PMID:
16514305
20.

Trends in predictors of death due to HIV-related causes among persons living with AIDS in New York City: 1993-2001.

Nash D, Katyal M, Shah S.

J Urban Health. 2005 Dec;82(4):584-600. Epub 2005 Oct 19.

Supplemental Content

Support Center